# Clot Dissolving Treatment for Blood Clots in the Lungs

> **NCT00680628** · PHASE3 · TERMINATED · sponsor: **Wake Forest University Health Sciences** · enrollment: 83 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Tenecteplase + Enoxaparin
- **DRUG:** 0.9% Saline + Enoxaparin

## Key facts

- **NCT ID:** NCT00680628
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-10
- **Target enrollment:** 83 (ACTUAL)
- **Why stopped:** PI changed institution and impossible to solve problem with contract's sites
- **Last updated:** 2022-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680628, "Clot Dissolving Treatment for Blood Clots in the Lungs". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00680628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*